ADHD and addiction: a study on methylphenidate
Part of Brain & nervous system, Mental health clinical trials.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You were diagnosed with ADHD less than 12 weeks ago.
- You also have a diagnosed addiction (to substances or behaviors).
- You haven't started taking methylphenidate yet.
- You can read and write French.
- You haven't used any drugs or alcohol in the last 12 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how methylphenidate (a common ADHD medicine) affects the body and brain in people with ADHD. You may be able to join if you have an ADHD diagnosis and meet specific health and medication-related requirements.
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
This study measures how stimulant medication (Adderall) affects college students with ADHD in the short term. It compares people with ADHD to students without ADHD to see what changes you may notice during the study.
This study looks at how the body processes methylphenidate (Ritalin) in adults with ADHD, comparing people with obesity (BMI 30 or higher) to those without. It aims to find out if weight affects the medication levels, which could help doctors adjust doses for better treatment.
This study tests whether adding a cognitive remediation program to methylphenidate (a medication for ADHD) improves treatment response in adults who have both ADHD and a substance use or behavioral addiction. It aims to help patients manage symptoms better over the short and medium term.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.